Evidence map›Paper›PMID 11880496›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2002

Phosphatidylinositol 4,5-bisphosphate modifies tubulin participation in phospholipase Cbeta1 signaling.

Juliana S Popova, Arin K Greene, Jia Wang, Mark M Rasenick

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Repurposing Terfenadine as a Novel Antigiardial Compound.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Juliana S PopovaDepartment of Physiology and Biophysics, University of Illinois at Chicago, College of Medicine, Chicago, Illinois 60612-7342, USA.
Arin K Greene
Jia Wang
Mark M Rasenick
University of Illinois Chicago · US

Funding

CYTOSKELETAL INTERACTION WITH NEURONAL ADENYLATE CYCLASER01MH039595 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RASENICK, MARK M · 1985 to 2006
$2.0M
REGULATION OF G PROTEIN MEDIATED PHOSPHOLIPID SIGNALINGR01AG015482 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RASENICK, MARK M · 1997 to 2001
$384k
NIA NIH HHS AG 15482NIA NIH HHS R01 AG015482NIMH NIH HHS MH 39595NIMH NIH HHS R01 MH039595
6 · The paper itself

Abstract

Tubulin forms the microtubule and regulates certain G-protein-mediated signaling pathways. Both functions rely on the GTP-binding properties of tubulin. Signal transduction through Galpha(q)-regulated phospholipase Cbeta1 (PLCbeta1) is activated by tubulin through a direct transfer of GTP from tubulin to Galpha(q). However, at high tubulin concentrations, inhibition of PLCbeta1 is observed. This report demonstrates that tubulin inhibits PLCbeta1 by binding the PLCbeta1 substrate phosphatidylinositol 4,5-bisphosphate (PIP2). Tubulin binding of PIP2 was specific, because PIP2 but not phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-phosphate, phosphatidylinositol, phosphatidylcholine, phosphatidylethanolamine, or inositol 1,4,5-trisphosphate inhibited microtubule assembly. PIP2 did not affect GTP binding or GTP hydrolysis by tubulin. Muscarinic agonists promoted microtubule depolymerization and translocation of tubulin to the plasma membrane. PIP2 augmented this process in both Sf9 cells, containing a recombinant PLCbeta1 pathway, and SK-N-SH neuroblastoma cells. Colocalization of tubulin and PIP2 at the plasma membrane was demonstrated with confocal laser immunofluorescence microscopy. Although tubulin bound to both Galpha(q) and PLCbeta1, PIP2 facilitated the interaction between tubulin and PLCbeta1 but not that between tubulin and Galpha(q). However, PIP2 did augment formation of tubulin--Galpha(q)-PLCbeta1 complexes. Subsequent to potentiating PLCbeta1 activation, sustained agonist-independent membrane binding of tubulin at PIP2- and PLCbeta1-rich sites appeared to inhibit Galpha(q) coupling to PLCbeta1. Furthermore, colchicine increased membrane-associated tubulin and also inhibited PLCbeta1 activity in SK-N-SH cells. Thus, tubulin, depending on local membrane concentration, may serve as a positive or negative regulator of phosphoinositide hydrolysis. Rapid changes in membrane lipid composition or in the cytoskeleton might modify neuronal signaling through such a mechanism.

Indexed as

AnimalsAzidesCarbacholCell LineCell MembraneCholinergic AgonistsDose-Response Relationship, DrugGreen Fluorescent ProteinsGTP-Binding Protein alpha Subunits, Gq-G11Guanosine TriphosphateHeterotrimeric GTP-Binding ProteinsHumansHydrolysisIsoenzymesLuminescent ProteinsPhosphatidylinositol 4,5-DiphosphateAzidesCarbacholCholinergic AgonistsGreen Fluorescent ProteinsGTP-Binding Protein alpha Subunits, Gq-G11GTP gamma-4-azidoanilideGuanosine TriphosphateHeterotrimeric GTP-Binding ProteinsIsoenzymesLuminescent ProteinsPhosphatidylinositol 4,5-DiphosphatePhospholipase C betaRecombinant Fusion ProteinsTubulinType C Phospholipases

Identifiers

PMID11880496
PMCPMC6758882
OpenAlexW2099515323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.